Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hayden Beresford"'
Autor:
Elise Burmeister Getz, Scott Haughie, Hayden Beresford, Svetlana Lyapustina, Christopher Wiggenhorn, Alessandro Cavecchi, J. David Christopher, Helen Strickland, Kevin J. Carroll, Beth Morgan
Publikováno v:
AAPS PharmSciTech
Batch-to-batch pharmacokinetic (PK) variability of orally inhaled drug products has been documented and can render single-batch PK bioequivalence (BE) studies unreliable; results from one batch may not be consistent with a repeated study using a diff
Autor:
Keyur Joshi, Elise Burmeister Getz, David Christopher, Thomas Hoffelder, Marisa Pertile, Svetlana Lyapustina, Monisha Dey, Beth Morgan, Stephen Andrews, Hayden Beresford, David Wilcox, Göran Långström, Helen Strickland, Mark R. Berry, Christopher Wiggenhorn, Stephanie T. Chen, Daniela Acerbi, Mary McKenry
Publikováno v:
AAPS PharmSciTech. 19:1410-1425
This article reports performance characteristics of the population bioequivalence (PBE) statistical test recommended by the US Food and Drug Administration (FDA) for orally inhaled products. A PBE Working Group of the International Pharmaceutical Aer
Autor:
Beth Morgan, David Christopher, Helen Strickland, Svetlana Lyapustina, Christopher Wiggenhorn, Stephanie T. Chen, Elise Burmeister Getz, Hayden Beresford, Göran Långström
Publikováno v:
AAPS PharmSciTech. 20(7)
This article extends previous work studying performance characteristics of the population bioequivalence (PBE) statistical test recommended by the US Food and Drug Administration (FDA) for orally inhaled and nasal drug products. Based on analysis of
Autor:
Bronwen A. Dekker, Surjeet Singh, Susan A. Watson, Andrew McKenzie, Myrto Lee, Hayden Beresford, Jane K. Sosabowski, Ben P. Simmons, Stephen J. Mather, Susan A. Hagan
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 31(2)
A DOTA-gastrin analogue (APH070) which, when labelled with (111)In, has high affinity for the gastrin/CCK-2 receptor (3nM) and low tumour to kidney ratio in animal models, has been formulated and manufactured for a clinical study. Oxidation of the pe
Autor:
Burmeister Getz, Elise, Carroll, Kevin J., Christopher, J. David, Morgan, Beth, Haughie, Scott, Cavecchi, Alessandro, Wiggenhorn, Christopher, Beresford, Hayden, Strickland, Helen, Lyapustina, Svetlana
Publikováno v:
AAPS PharmSciTech; Oct2021, Vol. 22 Issue 7, p1-11, 11p
Autor:
Pinto, J T, Radivojev, S, Fröhlich, E, Paudel, A, Lipworth, Brian, Vehring, Reinhard, Sheikh, Zara, Ong, Hui Xin, Pozzoli, Michele, Young, Paul, Traini, Daniela, Hellfritzsch, Marie, Scherlieβ, Regina, Gutowski, Tobias, Elserfy, K., Cheng, S., Chan, H-K., Hebbink, G., Mehta, M., Kourmatzis, A.
Publikováno v:
Journal of Aerosol Medicine & Pulmonary Drug Delivery; Apr2019, Vol. 32 Issue 2, pA-1-A-27, 27p
Autor:
Morgan, Beth, Chen, Stephanie, Christopher, David, Långström, Göran, Wiggenhorn, Christopher, Burmeister Getz, Elise, Beresford, Hayden, Hoffelder, Thomas, Acerbi, Daniela, Andrews, Stephen, Berry, Mark, Dey, Monisha, Joshi, Keyur, McKenry, Mary, Pertile, Marisa, Strickland, Helen, Wilcox, David, Lyapustina, Svetlana
Publikováno v:
AAPS PharmSciTech; Apr2018, Vol. 19 Issue 3, p1410-1425, 16p
Autor:
Chen, Stephanie, Morgan, Beth, Beresford, Hayden, Burmeister Getz, Elise, Christopher, David, Långström, Göran, Strickland, Helen, Wiggenhorn, Christopher, Lyapustina, Svetlana
Publikováno v:
AAPS PharmSciTech; Oct2019, Vol. 20 Issue 7, pN.PAG-N.PAG, 1p